These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7639052)

  • 1. 9th Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemias and Lymphomas. Genoa, June 23-27, 1995. Abstracts.
    Acta Haematol; 1995; 93(2-4):113-276. PubMed ID: 7639052
    [No Abstract]   [Full Text] [Related]  

  • 2. 10th Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemias and Lymphomas. Hamburg, Germany July 2-6, 1997. Abstracts.
    Acta Haematol; 1997; 98 Suppl 1():1-127. PubMed ID: 9251718
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of immunology in the treatment of leukemias and hematosarcomas.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
    Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
    [No Abstract]   [Full Text] [Related]  

  • 4. 13th Symposium in Molecular Biology of Hematopoiesis and Treatment of Leukemia and Cancer. New York, New York, USA. July 14-18, 2000. Abstracts.
    Acta Haematol; 2000; 103 Suppl 1():1-102. PubMed ID: 10983493
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes for leukemia and lymphoma.
    Bollard CM; Barrett AJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):565-9. PubMed ID: 25696912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD.
    Viret F; Chabannon C; Aurran-Schleinitz T; Reviron D; Stoppa AM; Faucher C; Ladaique P; Gastaut JA; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1999 Jul; 24(2):225-7. PubMed ID: 10455358
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic engineering of T cells in leukemia and lymphoma.
    Kochenderfer JN
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):190-2. PubMed ID: 24927269
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatic cell engineering and the immunotherapy of leukemias and lymphomas.
    Brentjens RJ; Sadelain M
    Adv Pharmacol; 2004; 51():347-70. PubMed ID: 15464917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collection and transplantation of hematopoietic stem cells of circulating blood].
    Körbling M; Fehrentz D; Rother K; Hunstein W
    Beitr Infusionsther; 1988; 21():322-34. PubMed ID: 2463003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal antibodies for lymphomas and leukemias in 2005].
    Peffault de Latour R; Robin M; Bay JO
    Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Biology of Hematopoiesis. Proceedings of the 9th symposium. Genoa, Italy, June 23-27, 1995.
    Acta Haematol; 1996; 95(3-4):155-278. PubMed ID: 8677735
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-dose effect in circulating stem-cell autografting.
    To LB; Dyson PG; Juttner CA
    Lancet; 1986 Aug; 2(8503):404-5. PubMed ID: 2874406
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular Biology of Hematopoiesis and Treatment of Leukemia and Cancer. Proceedings of the 13th Symposium. New York, New York, USA. July 14-18, 2000.
    Acta Haematol; 2001; 105(3):122-95. PubMed ID: 11534493
    [No Abstract]   [Full Text] [Related]  

  • 15. The Fifth Nagoya International Blood And Marrow Transplantation Symposium: unlimited possibilities of hematopoietic cell transplantation: lessons from the past and prospects for the future.
    Nakajima H; Akatsuka Y
    Int J Hematol; 2004 Feb; 79(2):200-4. PubMed ID: 15005353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
    Beatty PG
    Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic approaches to the classification and management of lymphomas and leukemias.
    Cancer Treat Res; 1988; 38():1-283. PubMed ID: 2908592
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allogeneic haematopoietic stem cell transplantation - an overview].
    Holtick U; Chemnitz JM; Hallek M; Scheid C
    Klin Monbl Augenheilkd; 2015 May; 232(5):641-6. PubMed ID: 25989032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A
    Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.